Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Correlation analysis of thrombin-activatable fibrinolysis inhibitor single nucleotide polymorphism with venous thromboembolism].

Zhongguo shi yan xue ye xue za zhi - 1 Aug 2012

Li Can, Hou Li-Hong, Liu Xiu-E, Huang Can, Wei Xiao-Hua

Abstract excerpt

This study was aimed to explore the change of single nucleotide polymorphism (SNP) of thrombin-activatable fibrinolysis inhibitor (TAFI) and its correlation of 2 sites (505a/g, 1040c/t) in its gene-coding region with venous thromboembolism (VTE). The genotype distribution of TAFI in 80 patients with VTE and 80 normal controls was detected by allele-specific PCR. The results showed that the distribution of each...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Carboxypeptidase B2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Gene Frequency

Share to Genotype

Share to Polymorphism, Single Nucleotide

Share to Venous Thromboembolism

Source

Identifiers

PMID: 22931662

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Correlation analysis of thrombin-activatable fibrinolysis inhibitor single nucleotide polymorphism with venous thromboembolism].PMID 22931662Read ↗

Association between thrombin-activatable fibrinolysis inhibitor gene polymorphisms and venous thrombosis risk: a meta-analysis.Semantic proximity Read ↗

Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis.Semantic proximity Read ↗

[The related analysis of venous thromboembolism and cSNPs of coagulation factor V gene].Semantic proximity Read ↗

[The investigation of angiotensin converting enzyme I/D and plasminogen activator inhibitor-1 4G/5G polymorphisms in venous thromboembolism patients].Semantic proximity Read ↗

Polymorphisms in the TAFI gene and the risk of venous thrombosis.Semantic proximity Read ↗

[Relationship of von Willebrand factor gene single-nucleotide polymorphism with thrombosis diseases].Semantic proximity Read ↗

Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis.Semantic proximity Read ↗

[Association of single nucleotide polymorphisms of tissue factor and tissue factor pathway inhibitor with venous thromboembolism in patients with lung cancer].Semantic proximity Read ↗

[Pathogenesis and prevention of thromboembolic complications in obstetric practice].Semantic proximity Read ↗

Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.Semantic proximity Read ↗

Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.Semantic proximity Read ↗

Is tissue-plasminogen activator gene polymorphism a risk factor for venous thromboembolism in every population?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.